D.E. Shaw & Co’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

D.E. Shaw & Co’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,266	Closed	-$59.7K	–	4377
2023 Q1	$59.7K	Sell	17,266 -80,254	-82%	-$389K	﹤0.01%	4022
2022 Q4	$408K	Buy	97,520 +6,325	+7%	+$23.9K	﹤0.01%	3964
2022 Q3	$366K	Buy	91,195 +22,095	+32%	+$168K	﹤0.01%	4214
2022 Q2	$781K	Sell	69,100 -13,099	-16%	-$157K	﹤0.01%	3793
2022 Q1	$1.33M	Buy	82,199 +16,914	+26%	+$433K	﹤0.01%	3669
2021 Q4	$3.09M	Sell	65,285 -155,996	-70%	-$9.36M	﹤0.01%	2921
2021 Q3	$16M	Buy	221,281 +62,823	+40%	+$4.54M	0.01%	1170
2021 Q2	$13.3M	Buy	158,458 +120,642	+319%	+$7.96M	0.01%	1272
2021 Q1	$1.83M	Buy	+37,816	New	+$2.05M	﹤0.01%	2662

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's NBP Position: Q2 2023 in Review

D.E. Shaw & Co sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 17,266 shares — an estimated $59.7K sold.

D.E. Shaw & Co first reported a position in NBP in Q1 2021 and held it in 9 quarters. The position peaked at $16M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

D.E. Shaw & Co reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
D.E. Shaw & Co sold 17,266 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $59.7K.
D.E. Shaw & Co first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 9 quarters.
D.E. Shaw & Co's NovaBridge Biosciences American Depositary Shares position peaked at $16M in Q3 2021.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.